Sanjana Shah

机构：Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center · ORCID：0000-0002-7389-328X

发表论文 35 篇 · 总被引 368 次 · h-index 9

代表论文

• The immunopathological landscape of human pre-TCRα deficiency: From rare to common variants (2024 · Science · 被引 38)
• Acquisition of optimal TFH cell function is defined by specific molecular, positional, and TCR dynamic signatures (2021 · Proceedings of the National Academy of Sciences · 被引 25)
• Epigenetic silencing of CD4 expression in nonpathogenic SIV infection in African green monkeys (2020 · JCI Insight · 被引 11)
• CEBPA repression by MECOM blocks differentiation to drive aggressive leukemias (2025 · Blood · 被引 8)
• Safety and Cost Implications of Same-Day Discharge Following Elective Percutaneous Closure of Patent Foramen Ovale and Atrial Septal Defects in Australia (2021 · Hearts · 被引 6)
• On-target toxicity limits the efficacy of CDK11 inhibition against cancers with 1p36 deletions (2025 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 4)